BR0107655A - Polinucleotìdeo isolado, vetor de expressão recombinante, polipeptìdeo, célula, método para produzir o polipeptìdeo, e, composição farmacêutica - Google Patents
Polinucleotìdeo isolado, vetor de expressão recombinante, polipeptìdeo, célula, método para produzir o polipeptìdeo, e, composição farmacêuticaInfo
- Publication number
- BR0107655A BR0107655A BR0107655-8A BR0107655A BR0107655A BR 0107655 A BR0107655 A BR 0107655A BR 0107655 A BR0107655 A BR 0107655A BR 0107655 A BR0107655 A BR 0107655A
- Authority
- BR
- Brazil
- Prior art keywords
- polypeptide
- cell
- pharmaceutical composition
- expression vector
- recombinant expression
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
- 239000013604 expression vector Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000003259 recombinant expression Methods 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 102000040430 polynucleotide Human genes 0.000 title 1
- 108091033319 polynucleotide Proteins 0.000 title 1
- 239000002157 polynucleotide Substances 0.000 title 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 229960003067 cystine Drugs 0.000 abstract 1
- 230000035558 fertility Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Reproductive Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
"POLINUCLEOTìDEO ISOLADO, VETOR DE EXPRESSãO RECOMBINANTE, POLIPEPTìDEO, CéLULA, MéTODO PARA PRODUZIR O POLIPEPTìDEO, E, COMPOSIçãO FARMACêUTICA". A invenção refere-se às seq³ências de DNA recentemente identificadas que codificam um novo polipeptídeo nó de cistina bem como à proteína codificada. A invenção é útil no campo da fertilidade.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00200185 | 2000-01-18 | ||
PCT/EP2001/000570 WO2001053346A1 (en) | 2000-01-18 | 2001-01-17 | Human cystine knot polypeptide |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0107655A true BR0107655A (pt) | 2002-10-15 |
Family
ID=8170926
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0107655-8A BR0107655A (pt) | 2000-01-18 | 2001-01-17 | Polinucleotìdeo isolado, vetor de expressão recombinante, polipeptìdeo, célula, método para produzir o polipeptìdeo, e, composição farmacêutica |
Country Status (9)
Country | Link |
---|---|
US (1) | US20030059877A1 (pt) |
EP (1) | EP1254175A1 (pt) |
JP (1) | JP2003520591A (pt) |
CN (1) | CN1395580A (pt) |
AU (1) | AU781389B2 (pt) |
BR (1) | BR0107655A (pt) |
CA (1) | CA2396283A1 (pt) |
IL (1) | IL150231A0 (pt) |
WO (1) | WO2001053346A1 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7034132B2 (en) | 2001-06-04 | 2006-04-25 | Anderson David W | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
CA2394420A1 (en) * | 1999-12-17 | 2001-06-21 | Takeda Chemical Industries, Ltd. | Novel polypeptide and dna thereof |
US7514239B2 (en) * | 2000-03-28 | 2009-04-07 | Amgen Inc. | Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptides and heterodimers thereof |
US20040005554A1 (en) * | 2000-05-08 | 2004-01-08 | Tayar Nabil El | Novel glycoproteins and methods of use thereof |
US20030219786A1 (en) * | 2000-08-11 | 2003-11-27 | Applied Research Systems Ars Holding N.V. | Novel glycoproteins and methods of use thereof |
EP1330469A2 (en) * | 2000-08-11 | 2003-07-30 | Applied Research Systems ARS Holding N.V. | Glycoproteins and methods of use therefof |
CA2600749C (en) * | 2005-03-10 | 2014-04-15 | Nascacell Ip Gmbh | Dimeric or multimeric microproteins |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2394420A1 (en) * | 1999-12-17 | 2001-06-21 | Takeda Chemical Industries, Ltd. | Novel polypeptide and dna thereof |
US20020160953A1 (en) * | 2000-04-25 | 2002-10-31 | Holloway James L. | Mammalian glycoprotein hormone-1 |
US20030095983A1 (en) * | 2001-07-13 | 2003-05-22 | Kelly James D. | Use of corticotroph-derived glycoprotein hormone to induce lipolysis |
-
2001
- 2001-01-17 AU AU37320/01A patent/AU781389B2/en not_active Ceased
- 2001-01-17 EP EP01909657A patent/EP1254175A1/en not_active Withdrawn
- 2001-01-17 CA CA002396283A patent/CA2396283A1/en not_active Abandoned
- 2001-01-17 WO PCT/EP2001/000570 patent/WO2001053346A1/en not_active Application Discontinuation
- 2001-01-17 JP JP2001553818A patent/JP2003520591A/ja not_active Withdrawn
- 2001-01-17 CN CN01803827A patent/CN1395580A/zh active Pending
- 2001-01-17 BR BR0107655-8A patent/BR0107655A/pt not_active IP Right Cessation
- 2001-01-17 IL IL15023101A patent/IL150231A0/xx unknown
- 2001-01-17 US US10/181,836 patent/US20030059877A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU3732001A (en) | 2001-07-31 |
US20030059877A1 (en) | 2003-03-27 |
WO2001053346A1 (en) | 2001-07-26 |
CA2396283A1 (en) | 2001-07-26 |
EP1254175A1 (en) | 2002-11-06 |
CN1395580A (zh) | 2003-02-05 |
JP2003520591A (ja) | 2003-07-08 |
IL150231A0 (en) | 2002-12-01 |
AU781389B2 (en) | 2005-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0113921A (pt) | ácidos nucléicos e polipeptìdeos receptores | |
FI961886A (fi) | Ihmisen Kunitz-tyyppiset proteaasi-inhibiittorit | |
BR0009392A (pt) | Polipeptìdeo, sequência de ácido nucleico, vetor de expressão recombinante, célula hospedeira recombinante, métodos para produzir uma sequência de ácido nucleico mutante e para produzir um polipeptìdeo, mutante de um polipeptìdeo com atividade de alafa-amilase, e, uso do polipeptìdeo ou variante | |
DK1660528T3 (da) | Mutein af tåre-lipocalin | |
BRPI0109131B8 (pt) | dna, vetor de expressão compreendendo o mesmo, fator viii modificado de porcino, seu processo de produção e composição terapêutica compreendendo o mesmo | |
HRP20040712B1 (hr) | Anti-amiloidna beta antitijela i njihova uporaba | |
AR036196A1 (es) | Agentes de contraste multimericos dirigidos a base de peptidos | |
DK289688A (da) | Ekspression af proapolipoprotein a-i. | |
BR0207325A (pt) | Métodos terapêuticos para doenças associadas com expressão diminuìda de gene de aop-1 ou aop-1 | |
BR0113286A (pt) | Pirazóis substituìdos | |
AR036202A1 (es) | Composiciones y metodos relacionados con el cluster genico biosintetico de daptomicina | |
ATE304603T1 (de) | Induzierendes alphavirengen- expressionssystem | |
BR0107655A (pt) | Polinucleotìdeo isolado, vetor de expressão recombinante, polipeptìdeo, célula, método para produzir o polipeptìdeo, e, composição farmacêutica | |
BR0313455A (pt) | modulação "antisense" da expressão de nav1.3 | |
DE69938240D1 (de) | Neuer g-protein-gekoppelter rezeptor | |
DE69736276D1 (de) | Menschliche dnase resistent gegen actininhibitoren | |
FI930626A (fi) | Proteinstruktur hos vaexttoxingelonin | |
BR9902019A (pt) | Moléculas de polinucleotìdios que codificam proteìnas de neospora. | |
AR022150A1 (es) | Acidos nucleicos derivados de monocitos y composiciones y metodos relacionados | |
BR0113623A (pt) | Proteìnas sintéticas de estìmulo da eritropoiese | |
DE69529235D1 (de) | Menschliche dnase i varianten | |
HUP0004739A1 (hu) | Presenilinekkel kölcsönhatásra képes fehérjéket kódoló nukleinsavak | |
BR0017015A (pt) | Toxina estafilocócica modificada, gene codificante, vetor de expressão, célula e métodos de produção de polipeptìdeo, de separação e purificação da toxina e de, produção de vacina. | |
BR9915537A (pt) | Gene prv-1 e sua utilização | |
BR0105179A (pt) | Proteìnas tendo atividade hemolìtica e genes que codificam a proteìna |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE 6A., 7A. E 8A. ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2012 DE 28/07/2009. |